With Dr. Glenn Barnhart; February 20, 2020
Dr. Glenn Barnhart is the CV Chief Emeritus of Swedish Heart and Vascular Institute in Seattle, Washington. Prior to his retirement in 2019, Dr. Barnhart was in practice for 32 years. During that time, he and his team were principal investigators in a number of significant clinical trials evaluating numerous new devices and procedural techniques in the areas of mitral disease, aortic disease, coronary disease and atrial fibrillation.
The key highlights of Dr. Barnhart’s presentation include:
- Describes current society guidelines support concomitant treatment
- Identifies peer-reviewed articles supporting mortality reduction of concomitant treatment vs. non-treatment
- Discusses perceived risks of concomitant treatment and why these perceptions may not be based upon current experience and current large-data evidence
- Reviews the key principles of the Cox-Maze procedure
- Explains how to sequence thesteps of the procedure based upon the primary procedure
- How to reduce aortic cross clamp time if that is a surgeon concern
- Postoperative care of the concomitant patient, considerations, medical management, and rhythm assessment
- Options and trade-offs of lesion sets in CABG, Aortic and Mitral valve procedures
